Showing 116 of 116on this page. Filters & sort apply to loaded results; URL updates for sharing.116 of 116 on this page
Medexus - End Brain Cancer
Medexus Pharmaceuticals Announces Pricing of $30 Million Overnight ...
Medexus Pharmaceuticals is poised for rapid growth, Mackie Research ...
Medexus Announces FDA Approval of GRAFAPEX (treosulfan) for Injection ...
Medexus Expands US Product Portfolio with IXINITY® Acquisition - Lumira ...
Medexus Pharmaceuticals Inc (TSX: MDP) – An Investment Opportunity
Today's Idea: Medexus Pharmaceuticals (MDP.T) Continues to Climb the ...
Medexus Healthcare and Diagnostics
Medexus Pharmaceuticals 2025 Company Profile: Stock Performance ...
Best Idea for 2025: Medexus – Stock Spinoff Investing
Medexus Inc. | LinkedIn
Working at Medexus | Glassdoor
Medexus Pharmaceuticals (MDP.T) Seeks Label Expansion, Completes ...
Medexus Pharmaceuticals Inc. (MEDXF) Stock Price, News, Quote & History ...
Why Medexus is a LEADER in Rare Disease Treatment Solutions 👈 - YouTube
Medexus Pharmaceuticals (MDP.TO) expects $27 million in Q2 2023
Medexus Pharma's (MDP.T) specialty pharma investment value on the rise ...
Medexus Pharmaceuticals Inc. (MDP.TO) Stock Price, News, Quote ...
Medexus Pharmaceuticals update on Treosulfan NDA resubmission
The Core Story: Medexus Pharmaceutical (MDP.T) just grows and grows ...
Medexus Pharmaceuticals (MDP.T) Announces Financial & Operational ...
Medexus Pharmaceuticals (MDP.TO) schedules Q2 2023 earnings call
Medexus Pharmaceuticals (MDP.T) Receives CRL from FDA for Treosulfan ...
Medexus Pharma with Gleolan at 11th Annual Miami Neuroscience Symposium ...
Medexus Pharmaceuticals (MDP.T) CEO picks up the gauntlet - Equity.Guru
Medexus Pharmaceuticals (MDP.TO) watch for THIS major catalyst!
Congratulations to Medexus Pharmaceuticals, a Lumira Ventures portfolio ...
Medexus CEO (MDP.T) on creating Canada’s specialty pharma success story ...
Medexus Pharmaceutical (MDP.T) readies for powerful year of growth in ...
Medexus Pharma (MDP.TO) Breaks Records: A Deep Dive into Quarterly ...
Medexus Pharmaceuticals Announces Closing of $30 Million Overnight ...
Medexus Announces Closing of $32.5 Million Public Offering, Including ...
Medexus Pharmaceuticals Sets New Revenue Records and Continues ...
Medexus Pharmaceuticals Inc. (TSX: MDP) (OTCQX: MEDXF) Webcast ...
Medexus Pharmaceuticals on LinkedIn: $MDP's core values help us provide ...
Medexus Q1 2026: GRAFAPEX Launch Drives Growth
Medexus Pharmaceuticals Raises $30 Million in Overnight Marketed Public ...
Medexus (MDP.TO) provides update on convertible debentures - Equity.Guru
Medexus Pharmaceuticals Inc (TSX:MDP) Q4 2025: Everything You Ne
Alain Béland on LinkedIn: Medexus Pharmaceuticals Announces C$10 ...
Medexus Announces Graduation to the Toronto Stock Exchange | citybiz
Medexus Pharmaceuticals (TSX: MDP, OTCQX: MEDXF) on LinkedIn: Gleolan ...
Medexus Pharmaceuticals (MDP.TO) brings in record breaking revenue
Medexus Pharmaceuticals – Dermatology Update
Medexus Pharmaceuticals Careers | Levels.fyi
Medexus Pharmaceuticals Empleos | Levels.fyi
Medexus Pharmaceuticals on LinkedIn: #mdpexcellence #bleedingdisorders ...
What is Brief History of Medexus Pharma Company? – PortersFiveForce.com
Medexus Pharmaceuticals (MDP.T) continues to build solid revenue - YouTube
Working at Medexus Pharma Inc. | Glassdoor
Learn about treosulfan, a conditioning treatment, at Medexus | Medexus ...
Medexus Pharmaceuticals Inc. (TSX-V:MDP) (OTCQX: MEDXF) Webcast | SNN ...
Medexus Pharmaceuticals Salaries | Levels.fyi
Medexus Pharmaceuticals on LinkedIn: #medexus #bt5ksf #bt5k
Medexus Pharmaceuticals (TSX: MDP, OTCQX: MEDXF) on LinkedIn: #medexus ...
Medexus Pharmaceuticals (MDP.T) - First Glance with Jody Vance E111 ...
Medexus Welcomes Two New Board Members | Frank Candido
Medexus Pharmaceuticals Investor Update: Fall 2022 - YouTube
Medexus (MDP.TO) expects record fiscal 2023 revenue - Equity.Guru
Medexus Pharmaceuticals (MDP.TO) is not just a Treosulfan stock
Medexus Pharmaceuticals has Outperform rating with Raymond James
Medexus Pharma (MDP.T) announces strong quarter results - Equity.Guru
Medexus Provides Update on Business Development Projects, Licensing ...
Medexus (MDP.TO) secures Canadian rights for fungal nail medication ...
Medexus (MDP.TO) stock drops hard on Q3 2024 results - Equity.Guru
Medexus (MDP.TO) announces strongest quarterly revenue of US$31.6 ...
Medexus Pharmaceuticals (MDP.T) deals with its debentures - Equity.Guru
Medexus (MDP.TO) reaches agreement with Quebec for Cuvposa
Health Canada accepts Medexus drug for review | Trevor Abes
Medexus Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Rx Item-Ixinity 3057IU VL by Medexus Pharma /Speciality USA
Medexus Pharmaceuticals (TSX: MDP, OTCQX: MEDXF) on LinkedIn: Last ...
Raymond James starts Medexus at OP; PT $5.50 (Canadian) - BioTuesdays
Medexus Pharma - Lumira Ventures | Venture Capital Life Sciences | Canada
Medexus (MDP.TO) announces preliminary Q1 2024 revenue - Equity.Guru
Medexus Pharmaceuticals on LinkedIn: As the year comes to a close and ...
Medexus Pharmaceuticals (MDP.T) Announces Type A Meeting for Treosulfan ...
Medexus Pharmaceuticals (MDP) Stock Price, News & Analysis
Medexus (MDP.TO) expects another record quarter for Q2 2023
Medexus Pharmaceuticals (MDP.T) building serious value - Equity.Guru
FDA Approves Medexus's Supplemental Biologics License Application for ...
Roth Conference Companies
The Sage Group Announces $100M+ Transaction between medac GmbH and ...
Attachment
RAliance Communications | Proven PR Success in Healthcare
SteriMax Inc. | Ontario at BIO-Europe 2023 | Source from Ontario
Partner - Giuliani | ricerca | Salute | Innovazione
9 Biotech Companies in Chicago Cultivating the City’s Life Sciences ...
ixinity-9
Medexus's (MDP.TO) new drug submission for fungal nail infections ...
Stifel Institutional | Canada
FDA Accepts for Review Medexus's IXINITY Supplemental Biological ...
